Latest news

  • VCA Fellowship targets ‘rare and aggressive’ childhood cancer

    Dr Jason Cain has been awarded a Victorian Cancer Agency (VCA) Mid-Career Fellowship for his research to help tackle a rare and aggressive form of childhood cancer. Dr Cain was one of 14 successful VCA funding recipients announced by Acting Minister for Health, Martin Foley as part of a $7 million investment by the Victorian…  Read more

  • Cutting edge genome editing toolbox for precision medicine

    A cutting-edge CRISPR library containing more than 36,000 molecular scissors targeting every known gene in the human genome is realising the clinical potential of precision medicine research at Hudson Institute. Hudson Institute scientists now have access to the award-winning Merck/Sanger Arrayed Whole Genome CRISPR Library on-site at the Monash Health Translation Precinct. Associate Professor Ron…  Read more

  • Professor Rosemary Horne awarded Doctor of Science

    Professor Rosemary Horne has been awarded a Doctor of Science from Monash University for more than three decades of research that has shaped the understanding of sleep in children and infants. The Doctor of Science (DSc) is of a higher standing than a PhD and is awarded for work that makes an original, substantial and…  Read more

  • Therapy brings long-term hope for halting Parkinson’s Disease

    How deep brain stimulation therapy could help to slow or halt the progression of Parkinson’s Disease is the focus of new research by Dr Joohyung Lee, thanks to a grant from the Bethlehem Griffiths Research Foundation. “Parkinson’s disease (PD) is primarily associated with the inability to initiate and control voluntary movement. These symptoms result from…  Read more

  • Simple blood test could decrease risk of stroke, heart attack

    Australia’s largest study of a common yet underdiagnosed cause of high blood pressure is starting at Hudson Institute, with the aim of preventing heart attack and stroke. Primary aldosteronism (PA) is a potentially curable cause of high blood pressure (hypertension) caused by the over-production of the hormone aldosterone from the adrenal glands. If left undiagnosed,…  Read more

  • Hudson Institute joins international paediatric cancer consortium

    Hudson Institute scientists will share expertise with leading international research institutions to progress research and improve treatments for children and adolescents with brain cancer. Hudson Institute has been announced as the first Australian member of the US-based Children’s Brain Tumor Tissue Consortium (CBTTC) and joins a collaborative, multi-institutional research program dedicated to the study and…  Read more

  • Stunning NHMRC Grant success

    Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. Our researchers have been awarded $14.8 million for 19 new NHMRC Project Grants to work on colorectal and gastric cancer, emphysema, fertility, lupus, gut bacteria and neonatal health. Overall the success rate for the institute was 31 per cent, well above the national…  Read more

  • Linking a common stomach bug to gastric cancer

    Why does a common bug, Helicobacter pylori, which is present in the stomachs of around half the world’s population, drive stomach cancer in some people? Associate Professor Richard Ferrero will establish how this seemingly innocuous bacterium drives growth of a specific type of stomach tumour, thanks to generous funding from the US Department of Defense.…  Read more

  • Disease of moving parts: examining the puzzle of cancer

    For more than 50 years, the idea that cancer is caused by abnormal genes has been driving cancer research and treatment. Now, discovery research into epigenetics (how genes are switched on and off), inflammation and tissue organisation (the interaction between cells and organs) is leading scientists to acknowledge that just like the human body, cancer…  Read more

  • 2018 Fielding Foundation Fellowship and Innovation Award announced

    Hudson Institute’s brightest scientific minds and most promising discoveries will be progressed, thanks to support from a leading philanthropist, Mr Peter Fielding and the Fielding Foundation. The 2018 Fielding Innovation Award has been awarded to Dr Maree Bilandzic to develop more effective treatments for women with ovarian cancer. The 2018 Fielding Foundation Fellowship has been…  Read more